Liabilities / Assets
99th percentile
Higher debt load relative to assets than 99% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
6.46x
Liabilities / Revenue
98th percentile
Higher debt load relative to revenue than 98% of similar nonprofits.
Net Margin
7th percentile
Higher net margin than 7% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
89th percentile
Faster asset growth than 89% of similar nonprofits.
Revenue Growth
Score unavailable
A valid growth rate could not be computed from the available filing history.
Balance Sheet
Assets
Up$1,394
Up $575 (+70%) from 2021
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Up$9,008
Up $2,433 (+37%) from 2021
Revenue And Expenses
Revenue
Up$2,000
Up $2,000 from 2021
Expenses
Up$3,858
Up $1,500 (+64%) from 2021
Net Income
Up-$1,858
Up $500 (+21%) from 2021
Historical Trend
Filing Detail Status
This 2022 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2022 to Dec 31, 2022
Mission and Program Overview
Mission
To raise funds to aid in the research for a cure for cystic fibrosis.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2022 • Form 990EZSummary only. Only limited summary data is available for this year.
- Assets
- $1,394
- Liabilities
- $9,008
- Net assets
- -
- Revenue
- $2,000
- Expenses
- $3,858
- Net income
- -$1,858